elranatamab will boost the level or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Elranatamab causes cytokine launch syndrome (CRS) that may suppress activity of CYP enzymes, leading to elevated exposure of CYP substrates.fentanyl transdermal and protriptyline both of those boost sedatio